Moreover, based on our results with doxorubicin resistance, the joint powers of all three factors together may further increase the resistance to chemotherapy in breast cancer patients, demonstrating another level at which the combined exposure to TNFα + Estrogen + EGF may be devastating to the patients. This evidence concerns the gene EGF and breast cancer.